CompletedPHASE2, PHASE3NCT02604186

Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia

Studying Autosomal recessive spastic paraplegia type 45

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Campinas, Brazil
Principal Investigator
Marcondes c França Júnior, M.D, PhD
University of Campinas, Brazil
Intervention
Botulinum Toxin Injections(other)
Enrollment
55 enrolled
Eligibility
18-80 years · All sexes
Timeline
20162017

Study locations (1)

Collaborators

Conselho Nacional de Desenvolvimento Científico e Tecnológico · Cristália Produtos Químicos Farmacêuticos Ltda.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02604186 on ClinicalTrials.gov

Other trials for Autosomal recessive spastic paraplegia type 45

Additional recruiting or active studies for the same condition.

See all trials for Autosomal recessive spastic paraplegia type 45

← Back to all trials